ketoconazole has been researched along with Atopic Hypersensitivity in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lintu, P | 1 |
| Savolainen, J | 1 |
| Kortekangas-Savolainen, O | 1 |
| Kalimo, K | 1 |
1 trial available for ketoconazole and Atopic Hypersensitivity
| Article | Year |
|---|---|
Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts.
Topics: Adolescent; Adult; Antifungal Agents; Dermatitis, Atopic; Double-Blind Method; Female; Finland; Foll | 2001 |